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This study investigated billiary secretory function in workers occupationally exposed to aluminium dust 
and fumes. It included a group of 34 male workers aged (44.1±7.8) years and exposed up to 4.6 mg m-3
of aluminium dust and fumes in workplace air for (21.6±2.5) years, and a group of 30 unexposed control 
male workers. Serum and urine aluminium levels were measured in both groups before and after chelating 
treatment with 1 g deferoxamine by intramuscular injection. Billiary function was assessed by measuring 
gamma-glutamyl transpeptidase, alkaline phosphatase, 5-nucleotidase, cholesterol and its fractions, total 
and indirect bilirubin, and bile acids. We then analysed the relationship between Al exposure and billiary 
function.
In the exposed group mean serum aluminium was significantly higher [(4.91±3.86) µg L-1] than in controls. 
The same was true for urine Al before [(1.57±1.93) µg L-1] and after deferoxamine [(11.51±14.97) µg
L-1]. Total and indirect bilirubin and alkaline phosphatase were significantly higher in the exposed than in 
control workers, and they correlated with urine Al after the chelating treatment.
Our findings suggest that chronic occupational exposure to aluminium dust and fumes leads to a significant 
body retention of aluminium. The impaired biliary secretion in the exposed workers manifested itself in 
subclinical signs of cholestasis.
KEY WORDS: aluminium, hepatic secretory function, occupational exposure
Bogdanovi} M, Bulat P. OCCUPATIONAL AL EXPOSURE AND BILIARY FUNCTION
Arh Hig Rada Toksikol 2008;59:135-139
* This paper has partly been presented at the International Symposium 
Safety and Health at Work in Metal Industry: 2007 - Focus on Aluminium 
Industry” held in Šibenik, Croatia on 24-26 May 2007.
Aluminium (Al) is ubiquitous in human environment. 
For many years people had thought that Al was 
not toxic, but when a connection between Al and 
neurological disturbances in patients on dialysis was 
found, more research of Al toxic effects followed. It has 
been discovered that large amounts of Al can cause 
neurological, bone and lung disorders, anaemia, 
glucose intolerance, and cardiac arrest. Exposure to 
Al may also cause irritation of the eyes and respiratory 
tract (1-7).
Al hepatotoxic effects are not considered important, 
even though Al partially aggregates in hepatocyte 
lysosomes (5). However, recent experimental studies 
have shown that Al can cause cholestasis. Al has 
been associated with a disbalance in the transport of 
organic molecules through sinusoidal and canalicular 
membrane, which is then reflected in the disturbance 
of bilirubin and bile salts emission (4, 6).
In view of this effect on the billiary secretory 
function, the aim of our study was to assess signs of 
cholestasis in workers exposed to Al dust and fumes. 
SUBJECTS AND METHODS
We examined a group of 34 workers who had been 
occupationally exposed to high Al concentrations 
in the form of dust and fumes for many years (the 
exposed group). They worked in Al electrolysis, in 
136
potrooms, in anode assemblies, electrolytic baths, and 
in the processing of liquid aluminium. The exposed 
workers were male, (44.1±7.8) years of age. Their 
average working experience was (21.6±2.5) years, 
while the exposure time was (12.7±4.1) years. The 
average Al concentration in the working atmosphere 
was 4.6 mg m-3.
The control group consisted of 30 men who had 
never been occupationally exposed to Al (controls). 
Their average age was (43.1±6.4) years.
We recorded subjective complaints and objective 
findings, laboratory blood and urine tests, and serum 
and urine Al before and after the implementation of 
a chelating agent. The same was performed in 30 
control subjects. 
Al concentrations in serum and urine were 
determined using a “Unicam” SP 90 A electrothermal 
atomic absorption spectrometer (ET AAS) (7). 
Reference values  for serum Al were (1.6 to 7.5) µg L-1
and for urine Al from (13±6) µg L-1 to (61±22) µg
L-1 per day.
Having obtained a written informed consent from 
the subject, we treated them with deferoxamine, a 
chelating agent, in order to estimate Al body burden. 
Deferoxamine is commonly indicated for treatment 
of exposed workers, if serum Al concentration 
exceeds 10 µg L-1, (8, 9). Deferoxamine was applied 
intramuscularly, in the dose of 1 g a day for three 
consecutive days (10).
To evaluate billiary secretory function, we used the 
following parameters: gamma-glutamyl transpeptidase 
(GGT) according to the Szasz method, alkaline 
phosphatase (ALP) according to the Bassey method, 
5-nucleotidase (5-NU) according to the Rosalka-
Wilson method, total and indirect bilirubin according 
to the Jendrassik-Groff method and glicocholic and 
glicochenodeoxicholic bile acids (CH and CHDK) 
according to the radioimmunoassay (RIA) method 
on a gamma scintillation counter “Compo Gamma 
1282” by Hofman (7).
The obtained data were processed for descriptive 
statistics, Student’s t-test, Mann-Whitney U-test, and 
multiple correlations test using the SPSS program 
(Statistical Package for the Social Sciences).
RESULTS
Table 1 shows serum and urine Al concentrations 
(before and after the application of the chelating 
agent). In the exposed workers they were significantly 
higher (p<0.01) than in controls. After provocation the 
difference was even more pronounced (p<0.005).
Liver elimination function is shown on Table 2. 
Total and direct bilirubin were higher in the exposed 
workers, while conjugated bilirubin did not differ 
between the groups. Blood bile acid concentration 
Table 1 Aluminium concentrations in serum and urine
Subjects
Aluminium /  µg L-1
Serum Urine 1 Urine 2
Exposed 4.91±3.86 1.57±1.93 11.5±14.97
Control 2.15±2.77 0.26±0.29 1.23±1.48
Level of significance* p<0.01 p<0.01 p<0.005
Results are expressed as arithmetic means and standard deviations
Urine 1: urine Al before administration of 1 g deferoxamine im;
Urine 2: urine Al during three days of administration 1 g deferoxamine im.
*(Student’s t-test)
Table 2 Bilirubin and bile acid blood concentrations as biomarkers ofliver elimination function
Subjects
Bilirubin / mmol L-1 Bile acids / µmol L-1
Total Direct Indirect CH CHDK
Exposed 14.2±3.58 4.54±3.17 10.1±3.37 1.41±1.05 2.36±2.07
Control 12.3±3.7 2.36±0.75 10.0±3.17 1.3±1.29 2.01±2.61
Level of significance* p<0.04 p<0.001 Not significant Not significant Not significant
Results are expressed as arithmetic means and standard deviations
CH - glicocholic; CHDK - glicochenodeoxicholic 
*(Student’s t-test)
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was higher in the exposed workers than in controls, 
but the difference was not statistically significant.
Table 3 shows the results of the test for cholestasis. 
Alkaline phosphatase activity was significantly 
greater in the exposed workers. Glicocholic and 
glicochenodeoxicholic bile acids were within normal 
limits and did not show statistical deviation between 
the groups.
Using correlation tests we established positive 
correlations between total bilirubin and total extracted 
Al content and also between indirect bilirubine and 
blood Al (Table 4).
Table 4 Multiple correlation test results
 Al-U1 Al-serum Al-U2
Total bilirubin 0.209 0.175 0.506*
Direct bilirubin 0.068 0.644* 0.091
Indirect bilirubin 0.139 0.357 0.395
CH 0.376 -0.401 0.39
CHDC 0.273 -0.357 0.294
ALP 0.062 0.4 0.246
5-NU 0.256 0.202 0.141
GGT -0.31 0.323 0.037
Al-U1: urine Al before administration of 1 g deferoxamine im.
Al-U2: urine Al during the three days of administration of 1 g 
deferoxamine im.
CH-glicocholic, CHDC-glicochenodeoxicholic, ALP-alkaline phosphatase, 
5-NU- 5 nucleotides, GGT-gamma-glutamyl-transpeptidase.
*(significant correlation)
DISCUSSION
In normal healthy adults serum and urine Al 
is about (4 to 10) µg L-1 and (3 to 30) µg L-1, 
respectively. Urine Al in exposed workers can reach 
up to (100 to 300) µg L-1 (2, 5, 6), depending on 
exposure intensity and duration.
The half-life of Al in human body after acute 
exposure is eight hours. During chronic, long-lasting 
exposure, Al accumulates in various tissues, bones, 
spleen, heart, and liver. Overall Al body load in non-
exposed persons reaches (35 to 40) mg (2, 5, 6). In 
exposed persons this body load is several times as 
high, and can be estimated by giving a chelating agent 
such as deferoxamine (8-10).
The exposed workers in our study have clearly 
shown increased Al body content, because serum 
and urine Al, before and after the administration of 
the chelating agent, were significantly higher than 
in non-exposed subjects. A statistically significant 
increase in both total and indirect bilirubin and alkaline 
phosphatase indicate cholestasis.
Our findings are in agreement with the results 
of other experimental studies of Al effects on billiary 
secretory function. In rats sub-chronically poisoned 
with Al bile salts increased in the while bile production 
dropped (11). Changes were also observed in bile 
acids glycine and taurine (12).
The latest research by Gonzales et al. (4) has 
shown that Al poisoning results in cholestasis, as 
it disturbs the transport of organic ions through 
sinusoidal and ductular membranes. Having in mind 
that the transport of organic ions is in close correlation 
with liver elimination of endo- and exotoxins, including 
bilirubin, bile salts, leukotriene C4, drugs and other 
substances, its disturbance can significantly affect 
the liver function.
However, the mechanism through which Al 
produces this effect is not even close to being 
explained. Gregus et al. in 1980 (13) and Ming-Tsang 
et al. in 1997 (14) found that Al disturbed protein 
synthesis, resulting in lower concentrations of a huge 
number of enzymes which take part in phase I and 
II detoxification such as  gluthatione-S-transferase, 
catalase, and glutathione peroxidase.
Latest research shows a very important role of 
oxidative stress. Al increases lipid peroxidation and 
at the same time decreases antioxidative activity of 
enzymes such as gluthatione-S-transferase, catalase 
and glutathione peroxidase (15, 16).
Table 3 Alkaline phosphatase, gamma-glutamyl–transpeptidase, and 5-nuleosidase as biomarkers of cholestasis
Subjects ALP / U L-1 5-NU / U L-1 GGT / U L-1
Exposed 30.6±8.01 1.85±0.99 7.55±4.68
Control 23.7±9.62 1.58±1.02 7.7±4.82
Level of significance* p<0.003 Not significant Not significant
Results are expressed by arithmetic means and standard deviations
ALP - alkaline phosphatase; GGT – gamma-glutamyl-transpeptidase; 5-NU - 5-nucleotidase
*(Student’s t-test)
Bogdanovi} M, Bulat P. OCCUPATIONAL AL EXPOSURE AND BILIARY FUNCTION
Arh Hig Rada Toksikol 2008;59:135-139
138
Oxidative stress caused by Al poisoning leads to a 
reduction of transportation molecules in the ductular 
membrane, which could be the cause for disturbed 
billiary secretory function (4).
CONCLUSION
Our workers with long-term exposure to Al 
dust and fumes showed a significantly increased 
Al body burden. In these workers the parameters 
of cholestasis, total and indirect bilirubin, and 
alkaline phosphatasewere significantly higher than 
in unexposed persons, even when they kept within 
reference limits. These findings show that prolonged 
exposure to Al induces cholestasis and impairs billiary 
secretory function in occupationally exposed workers, 
and call for inclusion of alkaline phosphatase in 
periodical checkups of Al-exposed workers.
REFERENCES
1.  Hathaway GJ, Proctor NH, Hughes JP, Fischman 
ML. Proctor and Hughes’ Chemical Hazards of the 
Workplace. 3rd ed. New York (NY): Van Nostrand 
Reinhold; 1991.
2.  Campbell A. The potential role of aluminium 
in Alzheimer’s disease. Nephrol Dial Transplant 
2002;17(Suppl 2):17-20.
3.  Blanu{a M, Prester Lj, Crnogorac M, Pureti} Z, Bubi}-
Filipi L, Dadi} Z. Aluminium in water for preparation 
of dialysate and in serum of dialyzed patients. Arh Hig 
Rada Toksikol 1997;48:197-204.
4.  Gonzalez M, Roma MG, Bernal CA, Alvarez AM, Carrillo 
MC. Biliary secretory function in rats chronically 
intoxicated with aluminum. Toxicol Sci 2004;79:189-
95.
5.  Vidakovi} A, editor. Profesionalna toksikologija 
[Occupational Toxicology, in Serbian]. 1st ed. Beograd: 
GIP Elvod-print; 2000.
6.  Flaten TP, Alfrey AC, Birchall JD, Savory J, Yokel RA. 
Status and future concern of clinical and environmental 
aluminium toxicology. J Toxicol Environ Health 
2004;19:527-42.
7.  Bogdanovi} M. Prilog poznavanju hepatotoksi~nih 
efekata metala u uslovima hroni~ne, profesionalne 
ekspozicije [Hepatotoxic effects of chronic, occupational 
exposure to metals, in Serbian]. [PhD thesis]. Belgrade: 
Medical school, University of Belgrade; 1991.
8.  Millner DS, Nebeker GH, Ott SM .Use of deferoxamine 
infusion test in the diagnosis of aluminium-related 
ostheodystrophy. Ann Intern Med 1984;101:775-89.
9.  Acrill P, Day NP. Deferoxamine in the treatment of 
aluminium overload. Clin Nephrol 1985;24(Suppl 1):
S94-7.
10.  International Programme on Chemical Safety 
Evaluation (IPCSE). WHO/ILO/UNEP Evaluation, 
antidotes for poisoning by metals and metalloids, 
deferoxamine [displayed 22nd April 2008] Available at 
http://www.inchem.org/documents/antidote/antidote/
deferoxamine.htm)
11.  Klein GL, Heyman MB, Lee TC, Miller NL, Marathe 
G, Gourley WK, Alfrey AC. Aluminum-associated 
hepatobiliary dysfunction in rats: Relationships 
to dosage and duration of exposure. Pediatr Res 
1988;23:275-8.
12.  Klein GL, Lee TC, Mann PA, Miller NL, Alfrey AC. Effects 
of aluminum on the liver following high-dose enteral 
administration to rats. J Pediatr Gastroenterol Nutr 
1989;9:105-7.
13.  Gregus Z, Fischer E, Varga F. Effect of cholestyramine-
induced bile acid depletion on the hepatobiliary 
transport of cholephilic organic anions in rats. Arch 
Int Pharmacodyn Ther 1980;245:311-22.
14.  Ming-Tsang WU, Fang Mau, Wypij D, Christiani DC. 
Serum liver function prifiles in coking workers. Am J 
Ind Med 1997;32:478-86.
15.  Gonzalez MA, Alvarez M del L, Pisani GB, Bernal CA, 
Roma MG, Carrillo MC. Involvement of oxidative stress 
in the impairment in biliary secretory function induced 
by intraperitoneal administration of aluminum to rats. 
Biol Trace Elem Res 2007;116:329-48.
16.  Abubakar MG, Taylor A, Ferns GA. Aluminium 
administration is associated with enhanced hepatic 
oxidant stress that may be offset by dietary vitamin E 
in the rat. Int J Exp Pathol 2003;84:49-54.
Bogdanovi} M, Bulat P. OCCUPATIONAL AL EXPOSURE AND BILIARY FUNCTION
Arh Hig Rada Toksikol 2008;59:135-139
139
Sa`etak
BILIJARNA FUNKCIJA U RADNIKA PROFESIONALNO IZLO@ENIH ALUMINIJSKOJ PRA[INI I DIMU
Eksperimentalna istra`ivanja na ̀ ivotinjama pokazuju da kroni~na izlo`enost aluminiju mo`e izazvati smanjen 
prijenos organskih aniona preko ̀ u~nih kanali}a, {to ima za posljedicu poreme}aje sekrecije ̀ u~i i kolestazu. 
U~inci kroni~ne izlo`enosti aluminiju na bilijarnu funkciju u ljudi do sada nisu istra`ivani. Procjenjivali smo 
u~inke na bilijarnu funkciju radnika koji su profesionalno izlo`eni pra{ini i dimu aluminija. U izlo`enoj 
skupini bila su 34 mu{karca, ̀ ivotne dobi (44,1±7,8) godina koji su tijekom (21,6±2,5) godina bili izlo`eni 
razini do 4,6 mg m-3 pra{ine i dima aluminija. Kontrolna skupina sastojala se od 30 neizlo`enih radnika. 
Vrijednosti aluminija odre|ene su u serumu i mokra}i u obje skupine prije i nakon davanja kelatiraju}eg 
spoja (deferoksamin u dozi od 1 g im.). Za procjenu bilijarne funkcije rabljeni su ovi pokazatelji: γ-glutamil
transpeptidaza, alkalna fosfataza, 5-nukleozidaza, kolesterol, ukupni i indirektni bilirubin te `u~ne kiseline. 
Analizirana je korelacija izme|u izlo`enosti aluminiju i bilijarne funkcije.
Srednja vrijednost Al u serumu izlo`enih radnika [(4,91±3,86) µg L-1], kao i koncentracije Al u mokra}i 
prije [(1,57±1,93) µg L-1] i nakon primjene kelatiraju}eg spoja [(11,5±15,0) µg L-1] bile su statisti~ki 
zna~ajno vi{e u odnosu na vrijednosti u kontrolnih ispitanika. Vrijednosti ukupnog i indirektnoog bilirubina 
te alkalne fosfataze bile su statisti~ki zna~ajno vi{e u izlo`enih radnika i pozitivno su korelirale s ukupnim 
Al izlu~enim mokra}om nakon primjene kelatora. Mo`e se zaklju~iti da kroni~na profesionalna izlo`enost 
pra{ini i dimu aluminija dovodi do tjelesnog optere}enja aluminijem i poreme}aja bilijarne funkcije, {to 
se odra`ava supklini~kim znakovima kolestaze. 
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